Physiological consequences of abnormal connectivity in a developmental epilepsy - PubMed
. 2015 Mar;77(3):487-503.
doi: 10.1002/ana.24343. Epub 2015 Jan 29.
Marine Vernet, Debby Klooster, Catherine J Chu, Katica Boric, Mollie E Barnard, Kelsey Romatoski, M Brandon Westover, Joanna A Christodoulou, John D E Gabrieli, Susan Whitfield-Gabrieli, Alvaro Pascual-Leone, Bernard S Chang
Affiliations
- PMID: 25858773
- PMCID: PMC4394240
- DOI: 10.1002/ana.24343
Physiological consequences of abnormal connectivity in a developmental epilepsy
Mouhsin M Shafi et al. Ann Neurol. 2015 Mar.
Abstract
Objective: Many forms of epilepsy are associated with aberrant neuronal connections, but the relationship between such pathological connectivity and the underlying physiological predisposition to seizures is unclear. We sought to characterize the cortical excitability profile of a developmental form of epilepsy known to have structural and functional connectivity abnormalities.
Methods: We employed transcranial magnetic stimulation (TMS) with simultaneous electroencephalographic (EEG) recording in 8 patients with epilepsy from periventricular nodular heterotopia and matched healthy controls. We used connectivity imaging findings to guide TMS targeting and compared the evoked responses to single-pulse stimulation from different cortical regions.
Results: Heterotopia patients with active epilepsy demonstrated a relatively augmented late cortical response that was greater than that of matched controls. This abnormality was specific to cortical regions with connectivity to subcortical heterotopic gray matter. Topographic mapping of the late response differences showed distributed cortical networks that were not limited to the stimulation site, and source analysis in 1 subject revealed that the generator of abnormal TMS-evoked activity overlapped with the spike and seizure onset zone.
Interpretation: Our findings indicate that patients with epilepsy from gray matter heterotopia have altered cortical physiology consistent with hyperexcitability, and that this abnormality is specifically linked to the presence of aberrant connectivity. These results support the idea that TMS-EEG could be a useful biomarker in epilepsy in gray matter heterotopia, expand our understanding of circuit mechanisms of epileptogenesis, and have potential implications for therapeutic neuromodulation in similar epileptic conditions associated with deep lesions.
© 2015 American Neurological Association.
Figures

T1-weighted MR brain images show unilateral posterior gray matter heterotopia along the wall of the lateral ventricle in one patient, subject 3 in Table 1 (sagittal image in A), and diffuse bilateral periventricular heterotopic nodules in another patient, subject 7 (axial image in B), as indicated by red arrows. BOLD images acquired in these patients reveal discrete regions of cerebral cortex that demonstrate aberrant functional connectivity with the heterotopic gray matter during the task-free resting state (green areas show significant functional activation in C and D); these regions were then chosen as cortical targets for TMS in our experimental design.

Cortical regions that demonstrate significant resting-state functional connectivity to periventricular gray matter nodules in eight patients with heterotopia, labeled according to subject number as listed in Table 1 and shown on surface brain MR renderings, were identified. Connected targets (red) for neuronavigation-guided TMS were then placed within these regions in each case. Non-connected cortical targets (blue), in regions without such connectivity, were also identified within the same hemisphere for each subject. Each control subject had neuronavigation-guided TMS of the same targets as his or her matched heterotopia subject.

A. The TMS-evoked response produced by stimulation of the connected target site in subject 2. Note the relatively large evoked potential at 289 ms as compared to earlier potentials. B. The GMFP between 100 and 700 ms after stimulation of the connected target in a PNH patient, subject 2 (solid black line), and his matched control (dashed red line). The pink region corresponds to the first time period (100 – 225 ms after the pulse), the blue to the second (225- 400 ms), and the yellow to the third (400 – 700 ms). C. The TMS-evoked response produced by stimulation of the same site (as in Panel A) in the matched control for subject 2. Note that the potential at 167 ms is substantially larger than later potentials. D. The ratio of the normalized AUC-GMFP after stimulation of the connected target for each of the 5 PNH subjects with active epilepsy to the equivalent measure in their matched healthy controls, during the 225-400 ms and 400-700 ms time periods. A ratio greater than 1 indicates an augmented late cortical response in the epilepsy patient (E) as compared to the healthy control (HC). E. The mean GMFP over time, across subjects, evoked by stimulation of the connected target site for the 5 PNH subjects with active epilepsy (thick black line) and their matched controls (thick dashed red line). The gray and red bands indicate +/− standard error of the mean. F. The normalized AUC-GMFP averaged across all PNH subjects with active epilepsy and their matched healthy controls during the same two time periods as in Panel D. Asterisks indicate significant differences (Bonferroni corrected p < 0.05). Note that the raw evoked potentials in A and C are not plotted on a uniform scale.

A. The TMS-evoked response produced by stimulation of the connected target site in subject 1. B. The TMS-evoked response produced by stimulation of the same site in the matched healthy control subject. The later peaks (>225 ms) in the PNH subject are of the same size as or larger than earlier peaks, whereas the later peaks are smaller than the earlier peaks in the matched healthy control subject. Notably, subject 1 had entirely normal interictal findings on prolonged continuous EEG monitoring. Note that the evoked potentials are not plotted on a uniform scale.

A. The mean GMFP over time, across all PNH subjects, evoked by stimulation of the connected target site (thick black line) and the non-connected target site (thick blue line). The gray and blue bands indicate +/− standard error of the mean. B. The ratio of the normalized AUC-GMFP after stimulation of the connected target to the equivalent measure after stimulation of the non-connected target in each of the PNH subjects, during the 225-400 ms and 400-700 ms time periods. A ratio greater than 1 indicates an augmented late cortical response after stimulation of the connected target (CT) as compared to the non-connected target (NCT). C. The mean GMFP over time, across all healthy control subjects, evoked by stimulation of the connected target site (thick dashed red line) and the non-connected target site (thick dashed purple line). The red and purple bands indicate +/− standard error of the mean. D. The normalized AUC-GMFP averaged across all connected and non-connected targets in the PNH subjects for the same two time periods as in Panel B. Asterisks indicate significant differences (Bonferroni corrected p < 0.05).

The plots show the differences between PNH patients with active epilepsy (subjects 1 through 5) and their matched healthy controls in the log-transformed normalized RMSV at each electrode evoked by stimulation of the connected target. Warm colors indicate regions where the evoked activity was greater in the patient; cool colors indicate that the evoked activity was greater in the control. Asterisks indicate the site of stimulation (the connected target site). The left side of each image represents the left side of the brain.

In subject 2, the only PNH patient in this study with an identifiable epileptogenic zone on scalp EEG, electrical source imaging was performed on the two late TMS-EEG peaks seen after stimulation of the connected target (A,B), two prominent interictal epileptiform discharges seen on conventional scalp EEG recording (C,E), and the ictal onsets of the two recorded seizures available on scalp EEG (D,F). Warm colors represent positive maxima, while cool colors represent negative maxima. In all instances, results converge on an area of the right frontal lobe that was not the site of stimulation, but overlapped with a cortical region that demonstrated functional connectivity to an underlying heterotopic nodule.
Similar articles
-
Shafi MM, Whitfield-Gabrieli S, Chu CJ, Pascual-Leone A, Chang BS. Shafi MM, et al. J Vis Exp. 2016 Nov 13;(117):53727. doi: 10.3791/53727. J Vis Exp. 2016. PMID: 27911366 Free PMC article.
-
Liu W, An D, Tong X, Niu R, Gong Q, Zhou D. Liu W, et al. Epilepsy Res. 2017 Oct;136:137-142. doi: 10.1016/j.eplepsyres.2017.08.007. Epub 2017 Aug 23. Epilepsy Res. 2017. PMID: 28850831
-
Emiliano S, Giampaolo V, Daniela M, Nicola P, Alfonso C, Raffaele R, Alessandro R. Emiliano S, et al. Epilepsy Res. 2012 Sep;101(3):280-3. doi: 10.1016/j.eplepsyres.2012.04.006. Epub 2012 Apr 26. Epilepsy Res. 2012. PMID: 22542195
-
Bauer PR, Kalitzin S, Zijlmans M, Sander JW, Visser GH. Bauer PR, et al. Int J Neural Syst. 2014 Mar;24(2):1430001. doi: 10.1142/S0129065714300010. Epub 2014 Jan 13. Int J Neural Syst. 2014. PMID: 24475894 Review.
-
Treatment of Epilepsy Associated with Periventricular Nodular Heterotopia.
Khoo HM, Gotman J, Hall JA, Dubeau F. Khoo HM, et al. Curr Neurol Neurosci Rep. 2020 Oct 30;20(12):59. doi: 10.1007/s11910-020-01082-y. Curr Neurol Neurosci Rep. 2020. PMID: 33123826 Review.
Cited by
-
Gefferie SR, Jiménez-Jiménez D, Visser GH, Helling RM, Sander JW, Balestrini S, Thijs RD. Gefferie SR, et al. Hum Brain Mapp. 2023 Jun 1;44(8):3446-3460. doi: 10.1002/hbm.26260. Epub 2023 Mar 10. Hum Brain Mapp. 2023. PMID: 36896753 Free PMC article. Review.
-
A structured ICA-based process for removing auditory evoked potentials.
Ross JM, Ozdemir RA, Lian SJ, Fried PJ, Schmitt EM, Inouye SK, Pascual-Leone A, Shafi MM. Ross JM, et al. Sci Rep. 2022 Jan 26;12(1):1391. doi: 10.1038/s41598-022-05397-3. Sci Rep. 2022. PMID: 35082350 Free PMC article.
-
Advancing the Neurophysiological Understanding of Delirium.
Shafi MM, Santarnecchi E, Fong TG, Jones RN, Marcantonio ER, Pascual-Leone A, Inouye SK. Shafi MM, et al. J Am Geriatr Soc. 2017 Jun;65(6):1114-1118. doi: 10.1111/jgs.14748. Epub 2017 Feb 6. J Am Geriatr Soc. 2017. PMID: 28165616 Free PMC article.
-
Contribution of transcranial magnetic stimulation to assessment of brain connectivity and networks.
Hallett M, Di Iorio R, Rossini PM, Park JE, Chen R, Celnik P, Strafella AP, Matsumoto H, Ugawa Y. Hallett M, et al. Clin Neurophysiol. 2017 Nov;128(11):2125-2139. doi: 10.1016/j.clinph.2017.08.007. Epub 2017 Sep 5. Clin Neurophysiol. 2017. PMID: 28938143 Free PMC article. Review.
-
Effects of antiepileptic drugs on cortical excitability in humans: A TMS-EMG and TMS-EEG study.
Darmani G, Bergmann TO, Zipser C, Baur D, Müller-Dahlhaus F, Ziemann U. Darmani G, et al. Hum Brain Mapp. 2019 Mar;40(4):1276-1289. doi: 10.1002/hbm.24448. Epub 2018 Dec 13. Hum Brain Mapp. 2019. PMID: 30549127 Free PMC article. Clinical Trial.
References
-
- Spencer SS. Neural networks in human epilepsy: evidence of and implications for treatment. Epilepsia. 2002;43:219–27. - PubMed
Publication types
MeSH terms
Grants and funding
- KL2 TR001100/TR/NCATS NIH HHS/United States
- R21 NS085491/NS/NINDS NIH HHS/United States
- 5K12NS066225/NS/NINDS NIH HHS/United States
- R21 HD07616/HD/NICHD NIH HHS/United States
- K23 NS092923/NS/NINDS NIH HHS/United States
- R21 NS082870/NS/NINDS NIH HHS/United States
- R01 NS073601/NS/NINDS NIH HHS/United States
- K12 NS066225/NS/NINDS NIH HHS/United States
- R21 MH099196/MH/NIMH NIH HHS/United States
- R01 HD069776/HD/NICHD NIH HHS/United States
- R21 HD077616/HD/NICHD NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical